Video: Logistics Leaders: Specialty pharmaceuticals vs cell and gene therapy supply chain

By Sam Herbert |

The key difference in cell and gene therapy is that the patient is in the supply chain. Find out more from Sam Herbert, President of World Courier. 

Video Transcript:

The key difference in cell and gene therapy is the patient is in the supply chain. Traditional small and large molecules use bulk manufacturing, whereas in cell and gene therapy, we're often extracting cells from the patient, moving them through a customized manufacturing process, and then infusing them back into the patient. These patients are often very sick and often close to death, so it really requires us going through elaborate contingency planning and us designing a customized solution that meets our manufacturer's needs.


About the Author

Portrait of Sam Herbert

Sam Herbert

President
World Courier
View Bio